Thieno pyrimidines as ferroportin inhibitors
US-12559502-B2 · Feb 24, 2026 · US
Global Blood Therapeutics Inc holds 157 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 157 |
| Recent patents | 22 |
| First publication | Feb 10, 2015 |
| Latest publication | Feb 24, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12559502-B2 · Feb 24, 2026 · US
US-12473277-B2 · Nov 18, 2025 · US
US-2025109122-A1 · Apr 3, 2025 · US
US-2025041312-A1 · Feb 6, 2025 · US
US-2025032471-A1 · Jan 30, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12559502-B2 · Feb 24, 2026 · US
US-12473277-B2 · Nov 18, 2025 · US
US-2025109122-A1 · Apr 3, 2025 · US
US-2025041312-A1 · Feb 6, 2025 · US
US-2025032471-A1 · Jan 30, 2025 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P7/06 | 74 |
| C07D401/04 | 72 |
| A61P7/00 | 61 |
| A61P35/00 | 51 |
| A61K31/4439 | 51 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 142 |
| Human Necessities | 127 |
| Cross-Sectional Technologies | 10 |
Answers are generated from the same data shown on this page.